Momelotinib sulfate
CAS: 1056636-06-6
Ref. 3D-GSB63606
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Momelotinib sulfate is a nucleoside that inhibits the tumor necrosis factor (TNF) receptor-associated protein 1 (TRAF1). It has been shown to be effective in treating thrombocytopenia, myeloproliferative neoplasms and myelofibrosis. Momelotinib sulfate has shown promising results in clinical trials for the treatment of myeloproliferative neoplasms and myelofibrosis. The drug works by inhibiting TNF-related apoptosis-inducing ligand (TRAIL) or its receptor, TRAF1. It also inhibits the production of interferon, which can increase the severity of some types of cancer.
Chemical properties
Technical inquiry about: 3D-GSB63606 Momelotinib sulfate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
